Antibiotic Resistance of Enteric Bacteria
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 382
Special Issue Editor
Interests: antimicrobial resistance (AMR); biofilm; environmental response; molecular genetics; bacterial pathogenicity; infection control
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The intestinal tract is the first reservoir of antimicrobial agents when orally administrated. Then, bacteria acquired the resistance can be dominantly selected at the site, and some genes responsible for the resistance are often transmitted to other members. Although most of enteric bacteria are opportunistic pathogens and its virulence is low at the enteric site, they can often cause severe diseases, such as sepsis, encephalosis, and endocarditis, when they enter the bloodstream. There are also some members that are highly virulent in the enteric site. To prevent and treat the severe infections, antimicrobial agents are commonly used; however, the bacteria have acquired resistance to conventional antibiotics. In this Special Issue, we collect papers from original basic research on antimicrobial resistance of enteric bacteria, including, but not limited to, identification/characterization of novel genes/proteins responsible for resistance, molecular studies on the resistance mechanism and gene transmission, and the proposal of strategies and/or methodologies to combat resistance. We also welcome review papers to provide up-to-date information concerning our topic.
Dr. Hidetada Hirakawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- drug resistance
- enteric bacteria
- infectious disease
- virulence
- bacterial translocation
- urinary tract infection
- biofilm
- combination chemotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.